Effect of Mipomersen on LDL-Cholesterol Levels in Patients with Severe LDL-Hypercholesterolemia and Atherosclerosis Treated by Regular LDL-Apheresis
Phase of Trial: Phase II
Latest Information Update: 22 Sep 2015
At a glance
- Drugs Mipomersen (Primary)
- Indications Atherosclerosis; Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms MICA
- 01 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Dec 2014 Planned End Date changed from 1 Nov 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov.
- 29 Dec 2014 Planned primary completion date changed from 1 Jun 2014 to 1 Apr 2015 as reported by ClinicalTrials.gov.